Boris Gorin, Ph.D.
Director, Research & Development

Dr. Boris Gorin, a native of Ukraine, obtained his Master of Science, Magna Cum Laude in chemistry, followed by a Ph.D. in synthetic organic chemistry from Moscow State University for his studies in the synthesis of heterocyclic compounds. Boris furthered his academic studies in Canada in the field of medicinal chemistry working with Dr. Greg Thatcher at Queens University, Kingston, Ontario from 1994-1996.

Boris has over 20 years of experience in synthetic organic chemistry and process development for the pharmaceutical industry. He started his industrial experience at the Institute for Physiologically Active Compounds, with the Russian Academy of Sciences, where he headed the drug design and discovery team. This was followed by his appointment as a Senior Research Chemist with Raylo Chemicals, in Edmonton, Alberta in 1996 where he worked until assuming his current position as Director, Research & Development with Alphora Research in 2004.

During his career, Boris has developed new synthetic processes for over one hundred new drug candidates, including various classes of natural products, heterocycles and phosphoroorganic compounds. Of these, several APIs were successfully launched to the pharmaceutical market. Boris is the author of over 50 patents and scientific publications.